The utilization and safety of apixaban for therapeutic anticoagulation in heart transplant population requiring routine endomyocardial biopsies.
Kristen E LindauerAmanda I IngemiMegan R McMahonAlicia LichvarDavid A BaranChad CameronAmit BadiyeEdward J SaweyWayne OldAndrew YaoAmin YehyaJohn M HerrePublished in: Clinical transplantation (2022)
Apixaban is safe to use for anticoagulation of heart transplant recipients undergoing routine biopsies. Using apixaban allows for a short interruption of therapeutic anticoagulation to accommodate a biopsy without increased risk of bleeding.